Prevalence and Course of SARS-CoV-2 Infection among Immunocompromised Children Hospitalised in the Tertiary Referral Hospital in Poland.

SARS-CoV-2 cancer immunodeficiency liver transplant paediatric population

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
30 Sep 2021
Historique:
received: 02 08 2021
revised: 23 09 2021
accepted: 26 09 2021
entrez: 13 10 2021
pubmed: 14 10 2021
medline: 14 10 2021
Statut: epublish

Résumé

The aim of this retrospective study was the assessment of the prevalence, clinical characteristics, and the comparison of the course of SARS-CoV-2 infection in children with and without immunodeficiency that were admitted to the COVID-19 Subunit of the tertiary referral hospital in Warsaw, Poland. We analysed 313 children hospitalised in the COVID-19 Subunit. The analysis was performed on the total study group and subgroups of children with and without immunodeficiency. In each group, clinical data and laboratory test results were analysed. Of the 68 children with isolated fevers, only seven (11.76%) were diagnosed with COVID-19, whereas among those with the accompanying features of respiratory or gastrointestinal infection, only one (3.23%) and ten (16.95%) patients tested positive, respectively. In both groups, the course of the infection was mainly asymptomatic or mild. The children with immunodeficiencies had lower white blood cell and lymphocyte counts, lower haemoglobin levels, and higher urea levels but did not differ in other biochemical variables. To conclude, the most frequently reported symptoms of COVID-19 indicate that this disease among children is only a small percentage. In both groups, the responses to the infection were comparable in terms of the mild clinical symptoms and the laboratory test results. Therefore, SARS-CoV-2 infection should not alter the chronic treatment of underlying diseases.

Identifiants

pubmed: 34640570
pii: jcm10194556
doi: 10.3390/jcm10194556
pmc: PMC8509507
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Clin Microbiol Rev. 2010 Jan;23(1):74-98
pubmed: 20065326
J Allergy Clin Immunol. 2020 Jul;146(1):211-213.e4
pubmed: 32333914
Pediatr Blood Cancer. 2020 Aug;67(8):e28410
pubmed: 32452123
Pediatr Res. 2021 Sep;90(3):637-641
pubmed: 33446913
Gastroenterology. 2021 Mar;160(4):1151-1163.e3
pubmed: 33307029
Front Pediatr. 2021 Apr 29;9:629240
pubmed: 33996683
Travel Med Infect Dis. 2020 Nov - Dec;38:101904
pubmed: 33137491
Liver Transpl. 2020 Oct;26(10):1359-1362
pubmed: 32614988
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
Front Pediatr. 2021 Mar 30;8:607647
pubmed: 33859967
United European Gastroenterol J. 2021 Mar;9(2):177-192
pubmed: 33704918
Pediatr Blood Cancer. 2021 Mar;68(3):e28843
pubmed: 33338306
Front Pediatr. 2021 Apr 09;9:613292
pubmed: 33898355
Br J Cancer. 2021 Feb;124(4):754-759
pubmed: 33299130
Pediatr Gastroenterol Hepatol Nutr. 2021 Jan;24(1):65-74
pubmed: 33505895
Am J Med Sci. 2020 Dec;360(6):740-741
pubmed: 32773108
Nat Biotechnol. 2021 Aug 18;:
pubmed: 34408314
J Infect. 2020 Jul;81(1):e61-e66
pubmed: 32335173
J Formos Med Assoc. 2020 Mar;119(3):670-673
pubmed: 32139299
Dtsch Arztebl Int. 2013 Nov 8;110(45):764-73; quiz 774
pubmed: 24290365
J Clin Immunol. 2021 Oct;41(7):1463-1478
pubmed: 34114122
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Bone Marrow Transplant. 2020 Oct;55(10):1900-1905
pubmed: 32313181

Auteurs

Karolina Kuczborska (K)

Department of Pediatrics, Nutrition and Metabolic Disorders, Children's Memorial Health Institute, 04-730 Warsaw, Poland.

Janusz Książyk (J)

Department of Pediatrics, Nutrition and Metabolic Disorders, Children's Memorial Health Institute, 04-730 Warsaw, Poland.

Classifications MeSH